Benralizumab Associated With Improvements in SGRQ Scores in Asthma
In patients with asthma, benralizumab is associated with substantial improvements in total scores on the St. George’s Respiratory Questionnaire.
In-Depth Focus From CHEST 2019: Asthma
Oral Montelukast Not Effective as Adjuvant in Pediatric Acute Moderate Asthma
Children with an acute exacerbation of asthma were randomly assigned to receive a single tablet of montelukast or placebo.
Despite Risks, Long-Term Oral Corticosteroid Use Still Common in Asthma
Despite the potential for adverse events, long-term use of oral corticosteroid medications is common among patients with poor asthma control.
Asthma Linked to Reduced Mortality in Adults Admitted for Myocardial Infarction
Asthma appeared to be associated with lower mortality in patients admitted to the hospital with myocardial infarction.
Dupilumab Reduced Severe Exacerbations in Oral Corticosteroid-Dependent Asthma
Dupilumab significantly reduced severe asthma exacerbations in patients with oral corticosteroid-dependent severe asthma with and without early improvements in lung function.
Mepolizumab Effective in Asthma Regardless of Background Controller Therapies
Irrespective of the type and number of background controller therapies, mepolizumab consistently reduced the annual rate of exacerbations in severe eosinophilic asthma compared with placebo.
Long-Term Asthma Control in Children: ICS With and Without LABA
Better asthma control in children can be achieved by either increasing inhaled corticosteroid dose or by switching to a combination of inhaled corticosteroid plus long-acting beta agonist with similar treatment outcomes.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in CHEST 2019 In-Depth Asthma
